Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Double-Blind, Randomized, Placebo-Controlled Trial of the Safety and Efficacy of Isolagen Therapy in the Treatment of Moderate to Sever Facial Acne Scarring

NCT00642642 is registered in ClinicalTrials.gov with Castle Creek Biosciences, LLC. as lead sponsor.

NCT NCT00642642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00642642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Double-Blind, Randomized, Placebo-Controlled Trial of the Safety and Efficacy of Isolagen Therapy in the Treatment of Moderate to Sever Facial Acne Scarring
Lead sponsor
Castle Creek Biosciences, LLC.
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2007
Completion date
March 31, 2009
Enrollment
122 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acne scarring of the face